116 related articles for article (PubMed ID: 35652586)
21. See the unseen: Mesorectal lymph node metastases in prostate cancer.
Hijazi S; Meller B; Leitsmann C; Strauss A; Ritter C; Lotz J; Meller J; Trojan L; Sahlmann CO
Prostate; 2016 Jun; 76(8):776-80. PubMed ID: 26880517
[TBL] [Abstract][Full Text] [Related]
22. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
[TBL] [Abstract][Full Text] [Related]
23. Increasing rate of lymph node invasion in patients with prostate cancer treated with radical prostatectomy and lymph node dissection.
Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Montorsi F; Saad F; Briganti A; Steuber T; Budäus L; Huland H; Graefen M; Tilki D; Karakiewicz PI
Urol Oncol; 2018 Aug; 36(8):365.e1-365.e7. PubMed ID: 29887241
[TBL] [Abstract][Full Text] [Related]
24. Management of the lymph nodes in penile cancer.
Heyns CF; Fleshner N; Sangar V; Schlenker B; Yuvaraja TB; van Poppel H
Urology; 2010 Aug; 76(2 Suppl 1):S43-57. PubMed ID: 20691885
[TBL] [Abstract][Full Text] [Related]
25. Obesity strongly predicts clinically undetected multiple lymph node metastases in intermediate- and high-risk prostate cancer patients who underwent robot assisted radical prostatectomy and extended lymph node dissection.
Tafuri A; Amigoni N; Rizzetto R; Sebben M; Shakir A; Gozzo A; Odorizzi K; De Michele M; Gallina S; Bianchi A; Ornaghi P; Brunelli M; De Marco V; Verratti V; Migliorini F; Cerruto MA; Artibani W; Antonelli A; Porcaro AB
Int Urol Nephrol; 2020 Nov; 52(11):2097-2105. PubMed ID: 32607958
[TBL] [Abstract][Full Text] [Related]
26. Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum.
Briganti A; Suardi N; Capogrosso P; Passoni N; Freschi M; di Trapani E; Gallina A; Capitanio U; Abdollah F; Tutolo M; Bianchi M; Salonia A; Da Pozzo LF; Montorsi F; Rigatti P
Prostate; 2012 Feb; 72(2):186-92. PubMed ID: 21538428
[TBL] [Abstract][Full Text] [Related]
27. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
Jacobs AJ; Morris CD; Levin AS
Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
[TBL] [Abstract][Full Text] [Related]
28. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
29. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
30. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
[TBL] [Abstract][Full Text] [Related]
31. Retrospective analysis of risk factors for bone metastasis in newly diagnosed prostate cancer patients.
Peng C; Juan C; Mao W; Jinghe Y; Renli T
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3832-3839. PubMed ID: 35731052
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.
Nini A; Gandaglia G; Fossati N; Suardi N; Cucchiara V; Dell'Oglio P; Cazzaniga W; Luzzago S; Montorsi F; Briganti A
Eur Urol; 2015 Nov; 68(5):777-84. PubMed ID: 25959166
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of 18F-fluciclovine PET/CT for regional lymph node metastases in patients with primary prostate cancer: a multicenter phase II clinical trial.
Suzuki H; Jinnouchi S; Kaji Y; Kishida T; Kinoshita H; Yamaguchi S; Tobe T; Okamura T; Kawakita M; Furukawa J; Otaka A; Kakehi Y
Jpn J Clin Oncol; 2019 Sep; 49(9):803-811. PubMed ID: 31095314
[TBL] [Abstract][Full Text] [Related]
34. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
[TBL] [Abstract][Full Text] [Related]
35. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
Kothari PS; Scardino PT; Ohori M; Kattan MW; Wheeler TM
Am J Surg Pathol; 2001 Nov; 25(11):1429-32. PubMed ID: 11684961
[TBL] [Abstract][Full Text] [Related]
36. Patterns of lymph node positivity on
McClinton C; Niroumand M; Sood S; Shah V; Hill J; Dusing RW; Shen X
Pract Radiat Oncol; 2017; 7(5):325-331. PubMed ID: 28377141
[TBL] [Abstract][Full Text] [Related]
37. Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
Gandaglia G; Fossati N; Zaffuto E; Bandini M; Dell'Oglio P; Bravi CA; Fallara G; Pellegrino F; Nocera L; Karakiewicz PI; Tian Z; Freschi M; Montironi R; Montorsi F; Briganti A
Eur Urol; 2017 Oct; 72(4):632-640. PubMed ID: 28412062
[TBL] [Abstract][Full Text] [Related]
38. Primary lymph-node staging with
Corona-Montes VE; González-Cuenca E; Fernández-Noyola G; Olarte-Casas MA; Bobadilla-Salazar D; Medrano-Urtecho HM; Asimakopoulos AD
Urol Oncol; 2021 Aug; 39(8):494.e1-494.e6. PubMed ID: 33223371
[TBL] [Abstract][Full Text] [Related]
39. Improving the Stratification of Patients With Intermediate-risk Prostate Cancer.
Stolzenbach LF; Nocera L; Collà-Ruvolo C; Tian Z; Knipper S; Maurer T; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2021 Apr; 19(2):e120-e128. PubMed ID: 33358891
[TBL] [Abstract][Full Text] [Related]
40. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.
de Jong IJ; Pruim J; Elsinga PH; Vaalburg W; Mensink HJ
J Nucl Med; 2003 Mar; 44(3):331-5. PubMed ID: 12620996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
